ロード中...
Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis
BACKGROUND AND PURPOSE: Oxidative stress has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Edaravone, a free radical scavenger, was approved as a therapeutic drug for ALS in 2015 in Japan. A phase 3 clinical trial demonstrated a smaller decline in ALS functional scale s...
保存先:
| 出版年: | eNeurologicalSci |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6006910/ https://ncbi.nlm.nih.gov/pubmed/29928711 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ensci.2018.05.001 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|